These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11499967)

  • 1. The impact of improved safety on maintaining a sufficient blood supply.
    Reynolds E; Wickenden C; Oliver A
    Transfus Clin Biol; 2001 Jun; 8(3):235-9. PubMed ID: 11499967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japan plans blood-donor restrictions to combat vCJD.
    Fuyuno I
    Nature; 2005 Mar; 434(7031):260. PubMed ID: 15772611
    [No Abstract]   [Full Text] [Related]  

  • 3. Current and emerging infectious risks of blood transfusions.
    Busch MP; Kleinman SH; Nemo GJ
    JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality and risk management: the commitment of the Council of Europe.
    Bopp KF
    Transfus Clin Biol; 2001 Jun; 8(3):218-9. PubMed ID: 11499962
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood groups differ on donor deferral.
    Mitka M
    JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
    [No Abstract]   [Full Text] [Related]  

  • 6. Does a perception of increased blood safety mean increased blood transfusion? An assessment of the risk compensation theory in Canada.
    Amin M; Wilson K; Tinmouth A; Hébert P
    BMC Public Health; 2004 Jun; 4():20. PubMed ID: 15182381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vCJD on blood supply.
    Seitz R; von Auer F; Blümel J; Burger R; Buschmann A; Dietz K; Heiden M; Hitzler WE; Klamm H; Kreil T; Kretzschmar H; Nübling M; Offergeld R; Pauli G; Schottstedt V; Volkers P; Zerr I
    Biologicals; 2007 Apr; 35(2):79-97. PubMed ID: 17320412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
    Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM
    Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region.
    Al-Riyami AZ; Abdella YE; Badawi MA; Panchatcharam SM; Ghaleb Y; Maghsudlu M; Satti M; Lahjouji K; Merenkov Z; Adwan A; Feghali R; Gebril N; Hejress S; Hmida S; AlHumaidan H; Jamal D; Najjar O; Raouf M
    Transfus Clin Biol; 2021 Feb; 28(1):16-24. PubMed ID: 33276150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

  • 11. Scotblood 2007: Tackling local and global issues in transfusion medicine - donor recruitment, effective use of blood, stem cell plasticity, and vCJD.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2008 Feb; 38(1):77-83. PubMed ID: 18282808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.
    Wilson K; Wilson M; Hébert PC; Graham I
    Transfus Med Rev; 2003 Apr; 17(2):89-94. PubMed ID: 12733102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies to reduce transfusion acquired vCJD.
    Wallis JP
    Transfus Med; 2011 Feb; 21(1):1-6. PubMed ID: 21070399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor selection: the exclusion of high risk donors?
    van den Burg PJ; Vrielink H; Reesink HW
    Vox Sang; 1998; 74 Suppl 2():499-502. PubMed ID: 9704489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Norway heading for a blood-supply crisis?
    Heier HE; Olaussen RW; Svenningsen VM
    Tidsskr Nor Laegeforen; 2012 Nov; 132(22):2508-10. PubMed ID: 23338034
    [No Abstract]   [Full Text] [Related]  

  • 17. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 18. Ireland fears blood shortage with new ban on donors.
    Payne D
    BMJ; 2001 Sep; 323(7311):469. PubMed ID: 11532827
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of variant CJD on transfusion practices in the UK.
    Boulton F
    Transfus Apher Sci; 2003 Apr; 28(2):107-16. PubMed ID: 12679113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.